| ESR1 mutant breast cancers show elevated basal cytokeratins and immune activation Z Li, O McGinn, Y Wu, A Bahreini, NM Priedigkeit, K Ding, S Onkar, ... Nature Communications 13 (1), 2011, 2022 | 39 | 2022 |
| Hotspot ESR1 Mutations Are Multimodal and Contextual Modulators of Breast Cancer Metastasis Z Li, Y Wu, ME Yates, N Tasdemir, A Bahreini, J Chen, KM Levine, ... Cancer research 82 (7), 1321-1339, 2022 | 35 | 2022 |
| Hotspot ESR1 mutations are multimodal and contextual drivers of breast cancer metastasis Z Li, Y Wu, ME Yates, N Tasdemir, A Bahreini, J Chen, KM Levine, ... BioRxiv, 2021.02. 10.430701, 2021 | 4 | 2021 |
| FOXA1 Reprogramming Dictates Retinoid X Receptor Response in ESR1-Mutant Breast Cancer Y Wu, Z Li, AM Wedn, AN Casey, D Brown, SV Rao, S Omarjee, J Hooda, ... Molecular Cancer Research 21 (6), 591-604, 2023 | 3 | 2023 |
| The EstroGene database reveals diverse temporal, context-dependent, and bidirectional estrogen receptor regulomes in breast cancer Z Li, T Li, ME Yates, Y Wu, A Ferber, L Chen, DD Brown, JS Carroll, ... Cancer Research 83 (16), 2656-2674, 2023 | 1 | 2023 |
| Abstract GS1-05: Hotspot ESR1 mutations rewire cell-cell adhesome to facilitate breast cancer metastasis Z Li, Y Wu, A Bahreini, J Chen, Y Qin, KM Levine, N Tasdemir, ... Cancer Research 81 (4_Supplement), GS1-05-GS1-05, 2021 | 1 | 2021 |
| Characterization of driver mutations in Chinese non-small cell lung cancer patients using a novel targeted sequencing panel J Zhao, Y Wu, MJ Chen, Y Xu, W Zhong, MZ Wang Journal of Thoracic Disease 14 (12), 4669, 2022 | | 2022 |
